Company profile CSTL
After 39 days of this quarter the interest is at 115.0. Based on that we can calculate that during remaining 52 days it will total up to 268.0. That appears to be equal to previous quarter and same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 83 | 138 66.3% QoQ | 260 88.4% QoQ | 129 -50.4% QoQ |
| 2020 | 177 113.3% YoY 37.2% QoQ | 144 4.3% YoY -18.6% QoQ | 226 -13.1% YoY 56.9% QoQ | 214 65.9% YoY -5.3% QoQ |
| 2021 | 603 240.7% YoY 181.8% QoQ | 537 272.9% YoY -10.9% QoQ | 206 -8.8% YoY -61.6% QoQ | 267 24.8% YoY 29.6% QoQ |
| 2022 | 309 -48.8% YoY 15.7% QoQ | 364 -32.2% YoY 17.8% QoQ | 408 98.1% YoY 12.1% QoQ | 193 -27.7% YoY -52.7% QoQ |
| 2023 | 286 -7.4% YoY 48.2% QoQ | 367 0.8% YoY 28.3% QoQ | 275 -32.6% YoY -25.1% QoQ | 302 56.5% YoY 9.8% QoQ |
| 2024 | 115 -59.8% YoY -61.9% QoQ | - | - | - |
The average 5 years interest of Castle Biosciences was 21.47 per week. The last year interest of Castle Biosciences compared to the last 5 years has changed by 10.25%. The interest for Castle Biosciences is seasonal. The last year interest is quite higher compared to 5 years ago. It has increased by 72.65%.
There is not enough data for Castle Biosciences testing services to provide analysis
There is not enough data for Castle Biosciences testing services to provide correlation calculation
There is not enough data for Castle Biosciences testing services to provide analysis
There is not enough data for DecisionDx-Melanoma to provide analysis
There is not enough data for DecisionDx-Melanoma to provide correlation calculation
There is not enough data for DecisionDx-Melanoma to provide analysis
There is not enough data for DecisionDx-UM to provide analysis
There is not enough data for DecisionDx-UM to provide correlation calculation
There is not enough data for DecisionDx-UM to provide analysis
There is not enough data for DecisionDx-SCC to provide analysis
There is not enough data for DecisionDx-SCC to provide correlation calculation
There is not enough data for DecisionDx-SCC to provide analysis
There is not enough data for myPath Melanoma to provide analysis
There is not enough data for myPath Melanoma to provide correlation calculation
There is not enough data for myPath Melanoma to provide analysis
There is not enough data for Castle Biosciences dermatological cancer to provide analysis
There is not enough data for Castle Biosciences dermatological cancer to provide correlation calculation
There is not enough data for Castle Biosciences dermatological cancer to provide analysis
After 39 days of this quarter the interest is at 47.0. Based on that we can calculate that during remaining 52 days it will total up to 110.0. Castle Biosciences stock price expected interest is significantly higher compared to same quarter last year (+233.3%) but lower than previous quarter (-64.4%).
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 119 | 136 14.3% QoQ | 98 -27.9% QoQ | 53 -45.9% QoQ |
| 2020 | 91 -23.5% YoY 71.7% QoQ | 67 -50.7% YoY -26.4% QoQ | 94 -4.1% YoY 40.3% QoQ | 107 101.9% YoY 13.8% QoQ |
| 2021 | 233 156.0% YoY 117.8% QoQ | 53 -20.9% YoY -77.3% QoQ | 75 -20.2% YoY 41.5% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 130 -44.2% YoY inf% QoQ | 19 -64.2% YoY -85.4% QoQ | 80 6.7% YoY 321.1% QoQ | 191 inf% YoY 138.8% QoQ |
| 2023 | 33 -74.6% YoY -82.7% QoQ | 123 547.4% YoY 272.7% QoQ | 223 178.8% YoY 81.3% QoQ | 309 61.8% YoY 38.6% QoQ |
| 2024 | 47 42.4% YoY -84.8% QoQ | - | - | - |
The average 5 years interest of Castle Biosciences stock price was 8.74 per week. The last year interest of Castle Biosciences stock price compared to the last 5 years has changed by 61.67%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 57.0%.
There is not enough data for Castle Biosciences Texas to provide analysis
There is not enough data for Castle Biosciences Texas to provide correlation calculation
There is not enough data for Castle Biosciences Texas to provide analysis
There is not enough data for Castle Biosciences competitors to provide analysis
There is not enough data for Castle Biosciences competitors to provide correlation calculation
There is not enough data for Castle Biosciences competitors to provide analysis